InMode Ltd.
INMD
$18.81
-$0.54-2.79%
Weiss Ratings | INMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Unrated | |||
Risk Index | Unrated | |||
Risk Grade | U | |||
Reward Grade | U | |||
Rating Factors | INMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Unrated | |||
Growth Index | Unrated | |||
Efficiency Index | Unrated | |||
Solvency Index | Unrated | |||
Total Return Index | Unrated | |||
Volatility Index | Unrated | |||
Beta / Standard Deviation | INMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.45 | |||
Price History | INMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.48% | |||
30-Day Total Return | 10.06% | |||
60-Day Total Return | 1.35% | |||
90-Day Total Return | 4.62% | |||
Year to Date Total Return | 10.91% | |||
1-Year Total Return | -12.67% | |||
2-Year Total Return | -39.46% | |||
3-Year Total Return | -48.38% | |||
5-Year Total Return | 54.18% | |||
52-Week High % Change | -12.92% | |||
52-Week Low % Change | 30.13% | |||
Price | INMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $22.22 | |||
52-Week Low Price | $14.87 | |||
52-Week Low Price (Date) | Oct 08, 2024 | |||
52-Week High Price (Date) | Mar 11, 2024 | |||
Valuation | INMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 1.35B | |||
Enterprise Value | 757.31M | |||
Price/Earnings (TTM) | 17.06 | |||
Earnings Per Share (TTM) | 1.13 | |||
Earnings Per Share Growth | -50.76% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 14.39 | |||
Price/Book (Q) | 1.91 | |||
Enterprise Value/Revenue (TTM) | 7.74 | |||
Price | $18.81 | |||
Enterprise Value/EBITDA (TTM) | 26.94 | |||
Enterprise Value/EBIT | 27.18 | |||
Market Cap Category | Small Cap | |||
Dividends and Shares | INMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 72.79M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | INMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 972 4 909 6313 | |||
Address | -- | |||
Website | www.inmodemd.com | |||
Country | Israel | |||
Year Founded | 2008 | |||
Profitability | INMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | INMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | -- | |||
Income Statement | INMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | $1.34 | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | -- | |||
Net Income Avl. to Common (TTM) | -- | |||
Total Revenue Growth (Q YOY) | -22.82% | |||
Earnings Growth (Q YOY) | 50.04% | |||
EPS Diluted (TTM) | -- | |||
EPS Diluted Growth (Q YOY) | 76.23% | |||
Balance Sheet | INMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 596.47M | |||
Cash Per Share (Q) | $8.19 | |||
Total Current Assets (Q) | 714.45M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 703.81M | |||
Current Ratio (Q) | 10.228 | |||
Book Value Per Share (Q) | $10.12 | |||
Total Assets (Q) | 785.67M | |||
Total Current Liabilities (Q) | 69.85M | |||
Total Debt (Q) | 7.82M | |||
Total Liabilities (Q) | 81.85M | |||
Total Common Equity (Q) | 703.81M | |||
Cash Flow | INMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -- | |||